Protein phosphorylation is a major mechanism of post-translational protein modification used to control cellular signaling. A challenge in phosphoproteomics is to identify the direct substrates of each protein kinase. Herein, we describe a chemical strategy for delivery of a bio-orthogonal affinity tag to the substrates of an individual protein kinase. The kinase of interest is engineered to transfer a phosphorothioate moiety to phosphoacceptor hydroxyl groups on direct substrates. In a second nonenzymatic step, the introduced phosphorothioate is alkylated with p-nitrobenzylmesylate (PNBM). Antibodies directed against the alkylated phosphorothioate epitope recognize these labeled substrates, but not alkylation products of other cellular nucleophiles. This strategy is demonstrated with Cdk1/cyclinB substrates using ELISA, western blotting, and immunoprecipitation in the context of whole cell lysates.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943827 | PMC |
| http://dx.doi.org/10.1021/ja050727t | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Formononetin Induces Ferroptosis in Activated Hepatic Stellate Cells to Attenuate Liver Fibrosis by Targeting NADPH Oxidase 4.
Phytother Res
December 2024
College of Pharmacy, Nantong University, Nantong, People's Republic of China.
Article Synopsis
- Ferroptosis is a newly identified form of cell death that plays an important role in liver fibrosis, and the natural compound Formononetin (FMN) shows potential in mitigating this condition.
- The research focuses on how FMN regulates liver fibrosis through its interaction with NADPH oxidase 4 (NOX4) and induces ferroptosis in hepatic stellate cells (HSCs) using an animal model.
- Results indicate that FMN can reduce fibrosis by promoting ferroptosis in activated HSCs, and it binds directly to NOX4, enhancing its activity and thereby supporting its therapeutic potential for liver fibrosis treatment.
G-Quadruplex mRNAs Silencing with Inducible Ribonuclease Targeting Chimera for Precision Tumor Therapy.
J Am Chem Soc
June 2024
State Key Laboratory of Chemo/Bio-Sensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, Hunan 410082, China.
Ribonuclease targeting chimera (RIBOTAC) represents an emerging strategy for targeted therapy. However, RIBOTAC that is selectively activated by bio-orthogonal or cell-specific triggers has not been explored. We developed a strategy of inducible RIBOTAC (iRIBOTAC) that enables on-demand degradation of G-quadruplex (G4) RNAs for precision cancer therapy.
View Article and Find Full Text PDFEfficient conversion of hemoglobin to a non-vasoactive oxygen carrier by site-specific cross-linking with azido acyl methyl phosphates followed by bio-orthogonal CuAAC with a bis-alkyne.
Bioorg Chem
August 2024
Department of Chemistry, University of Toronto, Canada. Electronic address:
Article Synopsis
- - Cross-linked hemoglobin tetramers can carry oxygen but can also negatively affect cardiovascular health by scavenging nitric oxide (NO) due to their ability to penetrate endothelial cells.
- - Animal studies show that chemically joining hemoglobins into larger double proteins helps avoid this NO scavenging by preventing penetration into NO-producing regions.
- - The research focuses on a new method using azide-containing acyl phosphate reagents to create larger hemoglobin conjugates that maintain oxygen affinity and could be useful in medical applications like organ perfusion.
Engineering Neurotoxin-Functionalized Exosomes for Targeted Delivery to the Peripheral Nervous System.
Pharmaceutics
January 2024
Mary and Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, NE 68198, USA.
The administration of therapeutics to peripheral nerve tissue is challenging due to the complexities of peripheral neuroanatomy and the limitations imposed by the blood-nerve barrier (BNB). Therefore, there is a pressing need to enhance delivery effectiveness and implement targeted delivery methods. Recently, erythrocyte-derived exosomes (Exos) have gained widespread attention as biocompatible vehicles for therapeutics in clinical applications.
View Article and Find Full Text PDFNanoconstruction on Living Cell Surfaces with Cucurbit[7]uril-Based Supramolecular Polymer Chemistry: Toward Cell-Based Delivery of Bio-Orthogonal Catalytic Systems.
J Am Chem Soc
December 2023
South China Advanced Institute for Soft Matter Science and Technology, School of Emergent Soft Matter, South China University of Technology, Guangzhou 510640, China.
Employing living cells as carriers to transport transition metal-based catalysts for target-specific bio-orthogonal catalysis represents a cutting-edge approach in advancing precision biomedical applications. One of the initial hurdles in this endeavor involves effectively attaching the catalysts to the carrier cells while preserving the cells' innate ability to interact with biological systems and maintaining the unaltered catalytic activity. In this study, we have developed an innovative layer-by-layer method that leverages a noncovalent interaction between cucurbit[7]uril and adamantane as the primary driving force for crafting polymeric nanostructures on the surfaces of these carrier cells.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!